Basic Pharmaceutical Product Manufacturing in Ireland - Industry Market Research Report

On the up: The ageing Irish population is boosting industry revenue in 2023

Demand for active substances produced by the Basic Pharmaceutical Product Manufacturing industry depends on consumer demand for pharmaceutical products. Over the past few years, an ageing Irish population has bolstered demand for pharmaceutical products, as pharmaceutical treatments for degenerative illnesses have become more popular. Rising obesity levels and associated health conditions, such as diabetes, have also lifted demand for pharmaceuticals. Basic Pharmaceutical Product Manufacturing revenue is anticipated to climb at a compound annual rate of 6.2% over the five years through 2023, including a forecast growth of 4.8% in 2023, to reach €16.9 billion. Companies in the Basic Pharmaceutical Product Manufacturing industry manufacture medicinal active substances that are used for their pharmacological properties to make medications, including antibiotics, basic vitamins, salicylic acids and aspirin. The industry also includes companies that process blood and glands and manufacture chemically pure sugars. This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.